{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T02:42:49Z","timestamp":1768876969555,"version":"3.49.0"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Department of Biotechnology (DBT), Government of India (GOI)","award":["BT\/PR7035\/MED\/12\/579\/2012"],"award-info":[{"award-number":["BT\/PR7035\/MED\/12\/579\/2012"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.gene.2018.04.076","type":"journal-article","created":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T02:44:46Z","timestamp":1524797086000},"page":"168-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Identifying causal variants at the interferon lambda locus in case-control studies: Utilizing non-synonymous variant rs117648444 to probe the role of IFN-\u03bb4"],"prefix":"10.1016","volume":"664","author":[{"given":"Anand","family":"Bhushan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sreedhar","family":"Chinnaswamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2018.04.076_bb0005","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.jhep.2010.09.019","article-title":"IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapy","volume":"54","author":"Abe","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.gene.2018.04.076_bb0010","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/jhg.2013.130","article-title":"Confounding by linkage disequilibrium","volume":"59","author":"Aissani","year":"2014","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.gene.2018.04.076_bb0015","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/infdis\/jit433","article-title":"Association of the IFNL4-\u0394G allele with impaired spontaneous clearance of hepatitis C virus","volume":"209","author":"Aka","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.gene.2018.04.076_bb0020","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/sj.ejhg.5200619","article-title":"Haplotypes vs single marker linkage disequilibrium tests: what do we gain?","volume":"9","author":"Akey","year":"2001","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.gene.2018.04.076_bb0025","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1590\/1678-4685-GMB-2015-0106","article-title":"Interferon lambda 4 (IFNL4) gene polymorphism is associated with spontaneous clearance of HCV in HIV-1 positive patients","volume":"39","author":"Alves","year":"2016","journal-title":"Genet. Mol. Biol."},{"key":"10.1016\/j.gene.2018.04.076_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084026","article-title":"Interferon-\u03bb4 (IFNL4) transcript expression in human liver tissue samples","volume":"8","author":"Amanzada","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2018.04.076_bb0035","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1093\/cid\/civ830","article-title":"Association of single-nucleotide polymorphisms in IL28B, but not TNF-\u03b1, with severity of disease caused by Andes virus","volume":"61","author":"Angulo","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.gene.2018.04.076_bb0040","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1080\/08820139.2016.1208215","article-title":"Increased serum levels of IL-28 and IL-29 and the protective effect of IL28B rs8099917 polymorphism in patients with Hashimotos thyroiditis","volume":"45","author":"Arpaci","year":"2016","journal-title":"Immunol. Investig."},{"key":"10.1016\/j.gene.2018.04.076_bb0045","first-page":"8","article-title":"IL28B gene polymorphism SNP rs8099917 genotype GG is associated with HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) in HTLV-1 carriers","volume":"e3199","author":"Assone","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.gene.2018.04.076_bb0050","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1089\/jir.2017.0002","article-title":"Confounding by single nucleotide polymorphism rs117648444 (P70S) affects the association of interferon lambda locus variants with response to interferon-\u03b1-ribavirin therapy in patients with chronic genotype 3 hepatitis C virus infection","volume":"37","author":"Bhushan","year":"2017","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.gene.2018.04.076_bb0055","article-title":"IL28B expression depends on a novel TT\/\u2212G polymorphism which improves HCV clearance prediction","volume":"20130012","author":"Bibert","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.gene.2018.04.076_bb0060","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.cell.2017.05.038","article-title":"An expanded view of complex traits: from polygenic to omnigenic","volume":"169","author":"Boyle","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.gene.2018.04.076_bb0065","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/ni.3821","article-title":"IFN\u03bb suppresses intestinal inflammation by non-translational regulation of neutrophil function","volume":"18","author":"Broggi","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.gene.2018.04.076_bb0070","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1053\/j.gastro.2005.01.059","article-title":"Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection","volume":"128","author":"Chen","year":"2005","journal-title":"Gastroenterology"},{"issue":"e3","key":"10.1016\/j.gene.2018.04.076_bb0075","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1053\/j.gastro.2009.10.046","article-title":"Cell-type specific gene expression signature in liver underlies response to interferon therapy in chronic hepatitis C infection","volume":"138","author":"Chen","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gene.2018.04.076_bb0080","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.meegid.2016.01.020","article-title":"IFNL4 ss469415590 polymorphism contributes to treatment decisions in patients with chronic hepatitis C virus genotype 1b, but not 2a, infection","volume":"39","author":"Wu","year":"2016","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.gene.2018.04.076_bb0085","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1089\/jir.2013.0113","article-title":"Genetic variants at the IFNL3 locus and their association with hepatitis C virus infections reveal novel insights into host-virus interactions","volume":"34","author":"Chinnaswamy","year":"2014","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.gene.2018.04.076_bb0090","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/gene.2016.24","article-title":"Gene-disease association with human IFNL locus polymorphisms extends beyond hepatitis C virus infections","volume":"17","author":"Chinnaswamy","year":"2016","journal-title":"Genes Immun."},{"key":"10.1016\/j.gene.2018.04.076_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075495","article-title":"A single nucleotide polymorphism associated with hepatitis C virus infections located in the distal region of the IL28B promoter influences NF-kB-mediated gene transcription","volume":"8","author":"Chinnaswamy","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2018.04.076_bb0100","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-10467-y","article-title":"A functional IFN-\u03bb4-generating DNA polymorphism could protect older asthmatic women from aeroallergen sensitization and associate with clinical features of asthma","volume":"7","author":"Chinnaswamy","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.gene.2018.04.076_bb0105","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3233\/JAD-170520","article-title":"Modulation of immune responses to herpes simplex virus type 1 by IFNL3 and IRF7 polymorphisms: a study in Alzheimer disease","volume":"60","author":"Costa","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.gene.2018.04.076_bb0110","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/apt.12568","article-title":"The novel ss469415590 variant predicts virological response to therapy in patients with chronic hepatitis C virus type 1 infection","volume":"39","author":"Covolo","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"e10","key":"10.1016\/j.gene.2018.04.076_bb0115","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1053\/j.gastro.2010.11.039","article-title":"Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C","volume":"140","author":"Dill","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gene.2018.04.076_bb0120","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/cid\/ciw833","article-title":"HLA-B* 57 and IFNL4-related polymorphisms are associated with protection against HIV-1 disease progression in controllers","volume":"64","author":"Dominguez-Molina","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.gene.2018.04.076_bb0125","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/infdis\/jiu144","article-title":"Immunomodulatory function of interleukin 28B during primary infection with cytomegalovirus","volume":"210","author":"Egli","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.gene.2018.04.076_bb0130","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12890-018-0616-6","article-title":"IFN\u039b3\/4 locus polymorphisms and IFN\u00ce3 circulating levels are associated with COPD severity and outcomes","volume":"18","author":"Egli","year":"2018","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.gene.2018.04.076_bb0135","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jhep.2014.03.039","article-title":"IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2\/3 infection","volume":"61","author":"Eslam","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.gene.2018.04.076_bb0140","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/ng.3836","article-title":"IFN-\u03bb3, not IFN\u03bb4, likely mediates IFNL3-IFNL4 haplotype dependent hepatic inflammation and fibrosis","volume":"49","author":"Eslam","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.gene.2018.04.076_bb0145","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1099\/jgv.0.000522","article-title":"IFN-\u03bb4 desensitizes the response to IFN-\u03b1 treatment in chronic hepatitis C through long-term induction of USP18","volume":"97","author":"Fan","year":"2016","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.gene.2018.04.076_bb0150","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/ajt.13107","article-title":"Association between individual and combined SNPs in genes related to innate immunity and incidence of CMV infection in seropositive kidney transplant recipients","volume":"15","author":"Fernandez-Ruiz","year":"2015","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.gene.2018.04.076_bb0155","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1128\/AAC.02239-12","article-title":"Combinations of lambda interferon with direct-acting antiviral agents are highly efficient in suppressing hepatitis C virus replication","volume":"57","author":"Friborg","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.gene.2018.04.076_bb0160","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1053\/j.gastro.2010.07.058","article-title":"Variants in IL28B in liver recepients and donorscorrelate with response to peg-interferon and ribavirin therapy for recurrent hepatitis C","volume":"139","author":"Fukuhara","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gene.2018.04.076_bb0165","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/liv.13526","article-title":"IFNL4 rs368234815 and rs117648444 variants predict off treatment HBsAg seroclearance in IFN treated HBeAg negative chronic hepatitis B patients","volume":"38","author":"Galmozzi","year":"2018","journal-title":"Liver Int."},{"key":"10.1016\/j.gene.2018.04.076_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030607","article-title":"Genetic variations in IL28B and allergic disease in children","volume":"7","author":"Gaudieri","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2018.04.076_bb0175","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/liv.13401","article-title":"A systematic review and meta-analysis of HCV clearance","volume":"37","author":"Gauthiez","year":"2017","journal-title":"Liver Int."},{"key":"10.1016\/j.gene.2018.04.076_bb0180","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.gene.2018.04.076_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146258","article-title":"Association with spontaneous hepatitis C viral clearance and genetic differentiation of IL28B\/IFNL4 haplotypes in populations from Mexico","volume":"11","author":"Gonzalez-Aldaco","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2018.04.076_bb0190","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1038\/emboj.2013.232","article-title":"Interferon lambda 4 signals via the IFNl receptor to regulate antiviral activity against HCV and coronaviruses","volume":"32","author":"Hamming","year":"2013","journal-title":"EMBO J."},{"key":"10.1016\/j.gene.2018.04.076_bb0195","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13005-017-0148-y","article-title":"The association between interleukin-28B gene polymorphisms as a potential biomarker and the risk of chronic periodontitis in an Iranian population","volume":"13","author":"Heidari","year":"2017","journal-title":"Head Face Med"},{"key":"10.1016\/j.gene.2018.04.076_bb0200","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1053\/j.gastro.2010.04.049","article-title":"Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C","volume":"139","author":"Honda","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gene.2018.04.076_bb0205","first-page":"20160437","article-title":"Interferon lambda 4 expression is suppressed by the host during viral infection","author":"Hong","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.gene.2018.04.076_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2013.00280","article-title":"A review of post-GWAS prioritization approaches","volume":"4","author":"Hou","year":"2013","journal-title":"Front. Genet."},{"key":"10.1016\/j.gene.2018.04.076_bb0215","article-title":"Genetic variants in interferon-\u00ce 4 influences HCV clearance in Chinese Han population","volume":"7","author":"Huang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.gene.2018.04.076_bb0220","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/hep.24263","article-title":"Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance","volume":"53","author":"di Iulio","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.gene.2018.04.076_bb0225","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4103\/ijmm.IJMM_16_309","article-title":"The evaluation of interferon lambda 4 rs368234815 as a predictor factor in treated patients with chronic hepatitis C genotype 1a infection","volume":"35","author":"Jalilian","year":"2017","journal-title":"Indian J. Med. Microbiol."},{"key":"10.1016\/j.gene.2018.04.076_bb0230","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/ng.3336","article-title":"Genome-wide significant risk associations for mucinous ovarian carcinoma","volume":"47","author":"Kelemen","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.gene.2018.04.076_bb0235","article-title":"The interferon lambda 4 rs368234815 predicts treatment response to pegylated-interferon alpha and ribavirin in hemophilic patients with chronic hepatitis C","volume":"21","author":"Keshvari","year":"2016","journal-title":"J. Res. Med. Sci."},{"key":"10.1016\/j.gene.2018.04.076_bb0240","first-page":"10","article-title":"Selection on a variant associated with improved viral clearance drives local, adaptive pseudogenization of interferon lambda 4 (IFNL4)","volume":"e1004681","author":"Key","year":"2014","journal-title":"PLoS Genet."},{"key":"10.1016\/j.gene.2018.04.076_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093011","article-title":"IL28B polymorphisms and clinical implications for hepatitis C virus infection in Uzbekistan","volume":"9","author":"Khudayberganova","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2018.04.076_bb0250","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/sj.ejhg.5200855","article-title":"The impact of genotyping error on haplotype reconstruction and frequency estimation","volume":"10","author":"Kirk","year":"2002","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.gene.2018.04.076_bb0255","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12881-014-0104-7","article-title":"Detection of allele specific differences in IFNL3 (IL28B) mRNA expression","volume":"15","author":"Knapp","year":"2014","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.gene.2018.04.076_bb0260","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-\u03bbs mediate antiviral protection through a distinct class II cytokine receptor complex","volume":"4","author":"Kotenko","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.gene.2018.04.076_bb0265","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jhep.2010.08.020","article-title":"Interferon-lambda serum levels in hepatitis C","volume":"54","author":"Langhans","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.gene.2018.04.076_bb0270","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/gene.2015.23","article-title":"Transcriptome analysis reveals a classical interferon signature induced by IFN \u03bb4 in human primary cells","volume":"16","author":"Lauber","year":"2015","journal-title":"Genes Immun."},{"key":"10.1016\/j.gene.2018.04.076_bb0275","doi-asserted-by":"crossref","DOI":"10.1038\/srep17030","article-title":"Polymorphisms near the IFNL3 gene associated with HCV RNA spontaneous clearance and hepatocellular carcinoma risk","volume":"5","author":"Lee","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.gene.2018.04.076_bb0280","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s00439-001-0656-4","article-title":"Effectiveness of computational methods in haplotype prediction","volume":"110","author":"Xu","year":"2002","journal-title":"Hum. Genet."},{"key":"10.1016\/j.gene.2018.04.076_bb0285","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijid.2016.10.023","article-title":"Correlation of interferon-lambda 4 ss469415590 with the hepatitis C virus treatment response and its comparison with interleukin 28b polymorphisms in predicting a sustained virological response: a meta-analysis","volume":"53","author":"Li","year":"2016","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.gene.2018.04.076_bb0290","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/aid.2011.0096","article-title":"IL28B polymorphism associated with spontaneous clearance of hepatitis C infection in a Southern Brazilian HIV type 1 population","volume":"28","author":"Lunge","year":"2012","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.gene.2018.04.076_bb0295","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/jvh.12817","article-title":"Role of functional IFNL4, IFNLR1, IFNA, IFNAR2 polymorphisms in hepatitis B virus-related liver disease in Han chinese population","volume":"25","author":"Ma","year":"2018","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.gene.2018.04.076_bb0300","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/infdis\/jis717","article-title":"IL28B single-nucleotide polymorphism rs12979860 is associated with spontaneous HIV control in white subjects","volume":"207","author":"Machmach","year":"2013","journal-title":"J. Infect. Dis."},{"issue":"289","key":"10.1016\/j.gene.2018.04.076_bb0305","article-title":"IFNL4 ss469415590 polymorphism is associated with unfavourable clinical and immunological status in HIV-infected individuals","volume":"21","author":"Machmach","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.gene.2018.04.076_bb0310","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1084\/jem.20111680","article-title":"Evolutionary genetic dissection of human interferons","volume":"208","author":"Manry","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.gene.2018.04.076_bb0315","doi-asserted-by":"crossref","DOI":"10.1038\/srep16037","article-title":"IFNL3 mRNA structure is remodeled by a functional non-coding polymorphism associated with hepatitis C virus clearance","volume":"5","author":"Lu","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.gene.2018.04.076_bb0320","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/ni.2758","article-title":"The favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus-induced microRNAs","volume":"15","author":"McFarland","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.gene.2018.04.076_bb0325","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.humimm.2016.09.007","article-title":"IL28B gene variants and glucose metabolism in Type 2 Diabetes","volume":"77","author":"Moran-Auth","year":"2016","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.gene.2018.04.076_bb0330","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/jmv.24763","article-title":"Hepatic IFNL4 expression is associated with non response to interferon-based therapy through the regulation of basal interferon stimulated gene expression in chronic hepatitis C patients","volume":"89","author":"Murakawa","year":"2017","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.gene.2018.04.076_bb0335","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s00535-013-0814-1","article-title":"Ex vivo induction of IFN-\u00ce3 by a TLR7 agonist determines response to Peg-IFN\/ribavirin therapy in chronic hepatitis C patients","volume":"49","author":"Murata","year":"2013","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.gene.2018.04.076_bb0340","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/gene.2015.11","article-title":"Hepatic expression levels of interferons and interferon-stimulated genes in patients with chronic hepatitis C: a phenotype-genotype correlation study","volume":"16","author":"Noureddin","year":"2015","journal-title":"Genes Immun."},{"key":"10.1016\/j.gene.2018.04.076_bb0345","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jhep.2015.06.035","article-title":"Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance","volume":"63","author":"O'Brien","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.gene.2018.04.076_bb0350","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1053\/j.gastro.2017.06.069","article-title":"IFNL4 genotype is associated with virologic relapse after 8-week treatment with sofosbuvir, velpatasvir, and voxilaprevir","volume":"153","author":"O'Brien","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gene.2018.04.076_bb0355","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1177\/1753425913503385","article-title":"IFNL3 mediates interaction between innate immune cells: implications for hepatitis C virus pathogenesis","volume":"20","author":"O'Connor","year":"2013","journal-title":"Innate Immun."},{"key":"10.1016\/j.gene.2018.04.076_bb0360","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.4049\/jimmunol.1700807","article-title":"IFN-\u03bb4 attenuates antiviral responses by enhancing negative regulation of IFN signaling","volume":"199","author":"Obajemu","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.gene.2018.04.076_bb0365","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1089\/jir.2013.0136","article-title":"IFN-\u03bb4: the paradoxical new member of the interferon lambda family","volume":"34","author":"O'Brien","year":"2014","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.gene.2018.04.076_bb0370","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019799","article-title":"Dysregulation of IFN system can lead to poor response to pegylated interferon and ribavirin therapy in chronic hepatitis C","volume":"6","author":"Onomoto","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2018.04.076_bb0375","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/liv.12411","article-title":"Variation in genes encoding for interferon \u00ce3 and \u00ce4 in the prediction of HCV-1 treatment-induced viral clearance","volume":"34","author":"Palmieri","year":"2014","journal-title":"Liver Int."},{"key":"10.1016\/j.gene.2018.04.076_bb0380","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jhep.2012.10.003","article-title":"Reply to: \u201cIL28B rs12979860 is not associated with histologic features of NAFLD in a cohort of Caucasian north American patients\u201d","volume":"58","author":"Petta","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.gene.2018.04.076_bb0385","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1002\/hep.29395","article-title":"Interferon lambda 4 rs368234815 TT> \u00ce\u2032G variant is associated with liver damage in patients with nonalcoholic fatty liver disease","volume":"66","author":"Petta","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.gene.2018.04.076_bb0390","doi-asserted-by":"crossref","DOI":"10.1098\/rspb.2015.1684","article-title":"Progress and promise in understanding the genetic basis of common diseases","volume":"282","author":"Price","year":"2015","journal-title":"Proc. R. Soc. B Biol. Sci."},{"key":"10.1016\/j.gene.2018.04.076_bb0395","doi-asserted-by":"crossref","first-page":"10678","DOI":"10.1073\/pnas.1602319113","article-title":"Prolonged activation of innate antiviral gene signature after childbirth is determined by IFNL3 genotype","volume":"113","author":"Price","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.gene.2018.04.076_bb0400","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng.2521","article-title":"A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus","volume":"45","author":"Prokunina-Olsson","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.gene.2018.04.076_bb0405","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1093\/jac\/dkr598","article-title":"Impact of IL28B gene polymorphisms on interferon-\u00ce3 plasma levels during pegylated interferon-\u03b1\/ribavirin therapy for chronic hepatitis C in patients coinfected with HIV","volume":"67","author":"Rallan","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.gene.2018.04.076_bb0410","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095515","article-title":"IFNL4 ss469415590 variant shows similar performance to rs12979860 as predictor of response to treatment against hepatitis C virus genotype 1 or 4 in Caucasians","volume":"9","author":"Real","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2018.04.076_bb0415","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1097\/QAD.0b013e32833a2a32","article-title":"Hepatitis C infection in HIV-1 natural viral suppressors","volume":"24","author":"Sajadi","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.gene.2018.04.076_bb0420","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.meegid.2017.07.023","article-title":"The impact of genetic variation in IL28B, IFNL4 and HLA genes on treatment responses against chronic hepatitis C virus infection","volume":"54","author":"Sakhaee","year":"2017","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.gene.2018.04.076_bb0425","doi-asserted-by":"crossref","first-page":"7034","DOI":"10.1073\/pnas.0707882105","article-title":"Interferon signaling and treatment outcome in chronic hepatitis C","volume":"105","author":"Sarasin-Filipowicz","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.gene.2018.04.076_bb0430","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ni873","article-title":"IL-28, IL-29 and their class II cytokine receptor IL-28R","volume":"4","author":"Sheppard","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.gene.2018.04.076_bb0435","article-title":"IL28B genetic variation is associated with spontaneous clearance of hepatitis C virus, treatment response, serum IL-28B levels in Chinese population","volume":"7","author":"Shi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2018.04.076_bb0440","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/gm273","article-title":"Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort","volume":"3","author":"Smith","year":"2011","journal-title":"Genome Med."},{"key":"10.1016\/j.gene.2018.04.076_bb0445","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/apt.12547","article-title":"Polymorphisms of interferon \u03bb 4 and IL28B effects on treatment response to interferon\/ribavirin in patients with chronic hepatitis C","volume":"39","author":"Stattermayer","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.gene.2018.04.076_bb0450","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1534\/genetics.110.120907","article-title":"Progress and promise of genome-wide association studies for human complex trait genetics","volume":"187","author":"Stranger","year":"2011","journal-title":"Genetics"},{"key":"10.1016\/j.gene.2018.04.076_bb0455","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026620","article-title":"Genetic variation of the IL-28B promoter affecting gene expression","volume":"6","author":"Sugiyama","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2018.04.076_bb0460","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1038\/s41598-017-04186-7","article-title":"IFN-\u03bb4 potently blocks IFN-\u03b1 signalling by ISG15 and USP18 in hepatitis C virus infection","volume":"7","author":"Sung","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.gene.2018.04.076_bb0465","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ng.447","article-title":"IL28B is associated with response to chronic hepatitis C interferon- \u03b1 and ribavirin therapy","volume":"41","author":"Suppiah","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.gene.2018.04.076_bb0470","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL28B with response to pegylated interferon- \u03b1 and ribavirin therapy for chronic hepatitis C","volume":"41","author":"Tanaka","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.gene.2018.04.076_bb0475","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1038\/ncomms6699","article-title":"Reduced IFN-\u03bb4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes","volume":"5","author":"Terczy\u0144ska-Dyla","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.gene.2018.04.076_bb0480","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1089\/jir.2013.0005","article-title":"Lambda interferon serum levels in patients with chronic hepatitis C virus infection according to their response to therapy with pegylated interferon and ribavirin","volume":"34","author":"Torres","year":"2013","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.gene.2018.04.076_bb0485","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/cis343","article-title":"Development of tropical spastic paraparesis in human T-lymphotropic virus type 1 carriers is influenced by interleukin 28B gene polymorphisms","volume":"55","author":"Trevino","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.gene.2018.04.076_bb0490","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1002\/hep.23912","article-title":"IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C","volume":"52","author":"Urban","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.gene.2018.04.076_bb0495","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ajhg.2017.06.005","article-title":"10\u202fyears of GWAS discovery: biology, function, and translation","volume":"101","author":"Visscher","year":"2017","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.gene.2018.04.076_bb0500","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/ni.3212","article-title":"Guarding the frontiers: the biology of type III interferons","volume":"16","author":"Wack","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.gene.2018.04.076_bb0505","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.32707","article-title":"Interferon lambda 4 polymorphism predicts sustained viral response in hepatitis C virus patients irrespective of hepatitis C virus genotypes, ethnicity or treatment regimen: results from a meta-analysis","volume":"15","author":"Wu","year":"2015","journal-title":"Hepat. Mon."},{"key":"10.1016\/j.gene.2018.04.076_bb0510","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.humimm.2016.05.007","article-title":"Association between IFNL4 rs368234815 polymorphism and sustained virological response in chronic hepatitis C patients undergoing PEGylated interferon\/ribavirin therapy: a meta-analysis","volume":"77","author":"Xie","year":"2016","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.gene.2018.04.076_bb0515","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.cgh.2014.01.043","article-title":"Effects of polymorphisms in interferon \u00ce 3 (interleukin 28B) on \u00c2 sustained virologic response to therapy in patients with chronic hepatitis D virus infection","volume":"12","author":"Yilmaz","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037811191830458X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037811191830458X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T23:36:36Z","timestamp":1751585796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037811191830458X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":103,"alternative-id":["S037811191830458X"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2018.04.076","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identifying causal variants at the interferon lambda locus in case-control studies: Utilizing non-synonymous variant rs117648444 to probe the role of IFN-\u03bb4","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2018.04.076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}